Cleveland Clinic Abu Dhabi picks G42’s Peng as new Chairman

The Cleveland Clinic, a pioneering U.S. medical center, has tapped Peng Xiao, Chief Executive of UAE tech powerhouse G42, to chair its Abu Dhabi branch.

The hospital announced on Wednesday that Peng was picked to lead the board as part of its effort to improve patient care through employing artificial intelligence in medical diagnostics and innovative treatments.

G42, which is owned by Abu Dhabi’s Royal Group and shareholders including Mubadala Investment Co. and Microsoft, has been at the forefront of the UAE’s efforts to become a leader in AI infrastructure and other advanced technologies. Peng has been CEO since its founding in 2018.

The Cleveland Clinic’s CEO and President, Dr. Tom Mihaljevic, hailed the appointment, saying in a statement that Peng will help the hospital “continue to grow as a beacon of excellence and innovation in the region.”

Peng expressed his commitment to expanding Cleveland Clinic Abu Dhabi’s services by marshaling the country’s technological resources.

“By combining the hospital’s renowned clinical expertise with advanced artificial intelligence, we will deliver earlier diagnoses, more precise therapies, and better outcomes for every patient,” Peng said.